Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK's NICE (National Institute for Clinical Excellence) appraisal of childhood inhalers appealed

This article was originally published in Clinica

Executive Summary

Draft guidance issued by the UK's health technology assessment body, the National Institute for Clinical Excellence (NICE), on inhaler systems for childhood asthma, has been appealed. In line with stated policy, NICE will not comment on the appraisal nor on the nature of the appeal, which was heard on August 31, until it issues its final guidance - due in mid-September at the earliest.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel